Algo version: 0.98b
ALK-Abelló A/S is listed at the OTC Exchange
ALK-Abelló A/S [AKABY]
OTC Sector: Healthcare Industry:Biotechnology

Is ALK-Abelló A/S stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, ALK-Abelló A/S pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Wednesday 15th of March 2017 were paid $0.14461 per share. Over the last 3 times between 2015 and 2017, ALK-Abelló A/S has paid $0.44757 with an average of $0.15 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for ALK-Abelló A/S 10 years ago, but if you had invested on Monday 24th of January 2022 when the price was $83.00, you would have made a profit of $7.00 per share or 8.43%

No, the average daily trading liquidity for ALK-Abelló A/S is $23 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

ALK-Abelló A/S has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.66, the company's ability to pay off the debt is good. ALK-Abelló A/S has a good net profit margin of 5.59% and should have high tolerances against inflation.

We have calculated the inflation risk for ALK-Abelló A/S to be low [0.25 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.